Market Size of Global Hemodynamic Monitoring Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 1.24 Billion |
Market Size (2029) | USD 1.48 Billion |
CAGR (2024 - 2029) | 3.58 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Hemodynamic Monitoring Devices Market Analysis
The Global Hemodynamic Monitoring Market size is estimated at USD 1.24 billion in 2024, and is expected to reach USD 1.48 billion by 2029, growing at a CAGR of 3.58% during the forecast period (2024-2029).
COVID-19 has a substantial market impact. According to the LiDCO Group PLC's annual report for 2020, demand for hemodynamic monitoring equipment has increased from many existing customers, with significant short-term heightened demand from UK hospitals and increased demand in several other countries, including a small number of monitors sold in Wuhan, China. Furthermore, some COVID-19 patients develop complications such as sepsis and require intensive care, and there is strong clinical evidence that using advanced hemodynamic monitoring improves patient outcomes. Hence, this is also likely to create more demand for the products till the pandemic ends.
The key factors propelling the growth of this market are an increase in the number of critically ill geriatric cases, a rise in the prevalence of cardiac disorders and diabetes, increasing demand for home-based and non-invasive monitoring systems, and an increase in the number of people suffering from hypertension. As per the World Health Organization's Fact of 2021, an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension. As per the same source, Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year, an estimated 32% of all the deaths worldwide. Hence the prevalence of cardiac disorders and hypertension will likely boost the market growth.
New techniques of hemodynamic monitoring have the potential to advance the management of the cardiovascular patient during postoperative care and anesthesia as they provide accurate and repeatable measurements that can be used to detect hemodynamic alterations and their causes, optimize hemodynamic conditions such as oxygen delivery to the tissues, and provide feedback on the adequacy of therapeutic interventions. The transition from static to dynamic variables to assess requirements such as cardiac preload and fluid responsiveness, as well as the change to less invasive or noninvasive monitoring techniques, are also driving the market growth.
Thus, the market is expected to show growth over the forecast period. However, Increasing incidences of complications associated with an invasive monitoring system and stringent FDA guidelines for approval of new systems may hinder the growth of the market.
Hemodynamic Monitoring Devices Industry Segmentation
As per the report's scope, critically ill patients require continuous monitoring of their vital parameters. This is done by direct pressure monitoring systems, also known as hemodynamic systems. The primary function of these systems is to monitor cardiac activity. The hemodynamic systems give blood pressure, volume, and fluid balance information. The Hemodynamic Monitoring Market is Segmented by System (Minimally Invasive Monitoring Systems, Invasive Monitoring Systems, and Non-invasive Monitoring Systems), Application (Laboratory-based Monitoring Systems, Home-based Monitoring Systems, Hospital-based Monitoring Systems), and, Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD million) for the above segments.
By System | |
Minimally Invasive Monitoring Systems | |
Invasive Monitoring Systems | |
Non-invasive Monitoring Systems |
By Application | |
Laboratory-based Monitoring Systems | |
Home-based Monitoring Systems | |
Hospital-based Monitoring Systems |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Hemodynamic Monitoring Market Size Summary
The hemodynamic monitoring systems market is poised for growth, driven by an increasing prevalence of critically ill geriatric cases, cardiac disorders, and diabetes. The demand for home-based and non-invasive monitoring systems is also on the rise, fueled by the growing number of individuals suffering from hypertension. The transition from static to dynamic variables in monitoring techniques, along with advancements in minimally invasive systems, is enhancing the accuracy and effectiveness of hemodynamic assessments. These developments are expected to propel market expansion over the forecast period, despite challenges such as complications associated with invasive monitoring systems and stringent regulatory approvals.
North America currently leads the hemodynamic monitoring market, with the United States holding a significant share due to its technologically advanced healthcare infrastructure and the presence of major market players. The region's growth is supported by increasing FDA approvals for monitoring devices and new product launches. The competitive landscape is characterized by the dominance of key players like Getinge Group, Koninklijke Philips NV, and Edwards Lifesciences Corporation, while mid-size and smaller companies are gaining traction through technological innovations and cost-effective solutions. These dynamics are anticipated to sustain the market's growth trajectory in the coming years.
Global Hemodynamic Monitoring Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Critically Ill Geriatric Population
-
1.2.2 Rise in the Prevalence of Cardiac Disorders and Diabetes
-
1.2.3 Technological Advanements
-
-
1.3 Market Restraints
-
1.3.1 Increasing Incidences of Complications Associated with Invasive Monitoring Systems
-
1.3.2 Stringent FDA Guidelines for Approval of New Systems
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By System
-
2.1.1 Minimally Invasive Monitoring Systems
-
2.1.2 Invasive Monitoring Systems
-
2.1.3 Non-invasive Monitoring Systems
-
-
2.2 By Application
-
2.2.1 Laboratory-based Monitoring Systems
-
2.2.2 Home-based Monitoring Systems
-
2.2.3 Hospital-based Monitoring Systems
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Hemodynamic Monitoring Market Size FAQs
How big is the Global Hemodynamic Monitoring Market?
The Global Hemodynamic Monitoring Market size is expected to reach USD 1.24 billion in 2024 and grow at a CAGR of 3.58% to reach USD 1.48 billion by 2029.
What is the current Global Hemodynamic Monitoring Market size?
In 2024, the Global Hemodynamic Monitoring Market size is expected to reach USD 1.24 billion.